|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Phase I Study of the Humanised
Anti-EGFR Monoclonal Antibody Matuzumab (EMD 72000) Combined
with Gemcitabine in Advanced Pancreatic Cancer Br J Cancer. 2006 May 8;94(9):1293-9.
PMID: 16622465 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |